130 related articles for article (PubMed ID: 35569709)
1. Changes in serum heavy metals in polycystic ovary syndrome and their association with endocrine, lipid-metabolism, inflammatory characteristics and pregnancy outcomes.
Zhang C; Xu L; Zhao Y; Wang Y
Reprod Toxicol; 2022 Aug; 111():20-26. PubMed ID: 35569709
[TBL] [Abstract][Full Text] [Related]
2. Exposure to multiple toxic metals and polycystic ovary syndrome risk: Endocrine disrupting effect from As, Pb and Ba.
Liang C; Zhang Z; Cao Y; Wang J; Shen L; Jiang T; Li D; Zou W; Zong K; Liang D; Xu X; Liu Y; Tao F; Luo G; Ji D; Cao Y
Sci Total Environ; 2022 Nov; 849():157780. PubMed ID: 35926607
[TBL] [Abstract][Full Text] [Related]
3. Association of Serum Heavy Metals and Trace Element Concentrations with Reproductive Hormone Levels and Polycystic Ovary Syndrome in a Chinese Population.
Zheng G; Wang L; Guo Z; Sun L; Wang L; Wang C; Zuo Z; Qiu H
Biol Trace Elem Res; 2015 Sep; 167(1):1-10. PubMed ID: 25758722
[TBL] [Abstract][Full Text] [Related]
4. Are Heavy Metal Exposure and Trace Element Levels Related to Metabolic and Endocrine Problems in Polycystic Ovary Syndrome?
Kirmizi DA; Baser E; Turksoy VA; Kara M; Yalvac ES; Gocmen AY
Biol Trace Elem Res; 2020 Nov; 198(1):77-86. PubMed ID: 32504400
[TBL] [Abstract][Full Text] [Related]
5. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant status in relation to heavy metals induced oxidative stress in patients with polycystic ovarian syndrome (PCOS).
Abudawood M; Tabassum H; Alanazi AH; Almusallam F; Aljaser F; Ali MN; Alenzi ND; Alanazi ST; Alghamdi MA; Altoum GH; Alzeer MA; Alotaibi MO; Abudawood A; Ghneim HK; Al-Nuaim LAA
Sci Rep; 2021 Nov; 11(1):22935. PubMed ID: 34824327
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
Falsetti L; Pasinetti E
Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
[TBL] [Abstract][Full Text] [Related]
8. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
9. L-Carnitine improves endocrine function and folliculogenesis by reducing inflammation, oxidative stress and apoptosis in mice following induction of polycystic ovary syndrome.
Kalhori Z; Mehranjani MS; Azadbakht M; Shariatzadeh MA
Reprod Fertil Dev; 2019 Jan; 31(2):282-293. PubMed ID: 31039949
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.
Samy N; Hashim M; Sayed M; Said M
Dis Markers; 2009; 26(4):163-70. PubMed ID: 19729797
[TBL] [Abstract][Full Text] [Related]
11. [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].
Chen Y; Wang XJ; Jin HL; Jin L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):751-6. PubMed ID: 23980352
[TBL] [Abstract][Full Text] [Related]
12. Effects of Cangfu Daotan Decoction on obese polycystic ovary syndrome and its mechanism.
Yi W; Li X; Chen K; Zhu M; Cai X; Pan A
Steroids; 2021 Jan; 165():108740. PubMed ID: 33137356
[TBL] [Abstract][Full Text] [Related]
13. The Association Between Prolactin and Metabolic Parameters in PCOS Women: A Retrospective Analysis.
Yang H; Di J; Pan J; Yu R; Teng Y; Cai Z; Deng X
Front Endocrinol (Lausanne); 2020; 11():263. PubMed ID: 32477263
[No Abstract] [Full Text] [Related]
14. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
15. Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome.
Yang H; Lin J; Li H; Liu Z; Chen X; Chen Q
Front Endocrinol (Lausanne); 2021; 12():571229. PubMed ID: 33716958
[TBL] [Abstract][Full Text] [Related]
16. The expression of platelet-derived growth factor, epidermal growth factor, and insulin-like growth factor-II in patients with polycystic ovary syndrome and its correlation with pregnancy outcomes.
Gao J; Song Y; Huang X; Wang D; Wang H
Ann Palliat Med; 2021 May; 10(5):5671-5678. PubMed ID: 34107718
[TBL] [Abstract][Full Text] [Related]
17. Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome.
Wang M; Zhao D; Xu L; Guo W; Nie L; Lei Y; Long Y; Liu M; Wang Y; Zhang X; Zhang L; Li H; Zhang J; Yuan D; Yue L
Metabolism; 2019 May; 94():47-58. PubMed ID: 30768966
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
19. Heavy Metals and Essential Elements in Association with Oxidative Stress in Women with Polycystic Ovary Syndrome-A Systematic Review.
Srnovršnik T; Virant-Klun I; Pinter B
Antioxidants (Basel); 2023 Jul; 12(7):. PubMed ID: 37507937
[TBL] [Abstract][Full Text] [Related]
20. Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology.
Krishnan A; Muthusami S; Periyasamy L; Stanley JA; Gopalakrishnan V; Ramachandran I
Medicina (Kaunas); 2020 Feb; 56(3):. PubMed ID: 32120970
[No Abstract] [Full Text] [Related]
[Next] [New Search]
